Ian Moore

No open positions remaining

Net worth: 77 744 $ as of 2026-06-29

Health Technology

Consumer Services

Health Services

Profile

Ian Roger Moore served as the Chairman of Novo Nordisk Pharma Ltd. from 2005 to 2007.
He also worked as an Independent Non-Executive Director at Proteomics International Laboratories Ltd. from 2016 to 2024.
Additionally, he was a Member-Management Board at Novo Nordisk A. Mr. Moore completed his undergraduate degree at The University of Sydney.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PROTEOMICS INTERNATIONAL LABORATORIES LTD. 0.59%	2024-11-07	975,824 ( 0.59% )	77 744 $	2026-06-29

Former positions of Ian Moore

Companies	Position	End
PROTEOMICS INTERNATIONAL LABORATORIES LTD	Director/Board Member	2024-11-07
Novo Nordisk Pharma Ltd. Novo Nordisk Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces drugs and insulins	Chairman	2006-12-31
NOVO NORDISK A/S	Corporate Officer/Principal	-

See the detail of Ian Moore's experience

Training of Ian Moore

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ian Moore's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
The University of Sydney The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novo Nordisk Pharma Ltd. Novo Nordisk Pharma Ltd. Pharmaceuticals: MajorHealth Technology Produces drugs and insulins	Health Technology
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd. Medical/Nursing ServicesHealth Services Provides biological research and drug discovery services	Health Services